Sandra D. van der Vaart - 29 Jun 2023 Form 4 Insider Report for LABORATORY CORP OF AMERICA HOLDINGS (LH)

Signature
/s/ Sandra D. van der Vaart
Issuer symbol
LH
Transactions as of
29 Jun 2023
Net transactions value
-$50,880
Form type
4
Filing time
03 Jul 2023, 11:52:02 UTC
Previous filing
21 Jun 2023
Next filing
05 Jul 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LH Common Stock Sale $50,880 -212 -2.7% $240.00 7,605 29 Jun 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
F2 Amount includes 25.9383 shares acquired on May 31, 2023 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan.